ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,667Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 15

$426K Total Retail Price of All Prescriptions

Rank: 6 out of 15

665 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 665 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

11% of this provider’s 665 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 9,719 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $38 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 569 515 1 2
LEVOTHYROXINE SODIUM 462 433 2 3
OMEPRAZOLE 356 305 3 7
HYDROCHLOROTHIAZIDE 320 304 4 13
HYDROCODONE-ACETAMINOPHEN 291 261 S3 5 5
SIMVASTATIN 285 275 6 6
FUROSEMIDE 284 243 7 4
METOPROLOL TARTRATE 275 256 8 11
LOVASTATIN 253 201 9 40
AMLODIPINE BESYLATE 244 232 10 9
CITALOPRAM HBR 223 164 11 10
WARFARIN SODIUM 219 199 12 1
ATENOLOL 214 195 13 23
GABAPENTIN 205 170 14 12
METFORMIN HCL 198 180 15 16
ZOLPIDEM TARTRATE 192 172 16 41
POTASSIUM CHLORIDE 188 171 17 8
POLYETHYLENE GLYCOL 3350 169 169 18 29
METOPROLOL SUCCINATE 148 130 19 20
PREDNISONE 115 94 20 30
DIGOXIN 113 113 21 34
TAMSULOSIN HCL 98 98 22 26
ALENDRONATE SODIUM 87 86 23 46
NOVOLOG MIX 70-30 87 87 23 100
DONEPEZIL HCL 86 85 25 15
ATORVASTATIN CALCIUM 84 80 26 18
ALLOPURINOL 81 77 27 36
FAMOTIDINE 80 80 28 104
GLIMEPIRIDE 79 65 29 105
TRIAMCINOLONE ACETONIDE 78 74 30 86
CYCLOBENZAPRINE HCL 75 68 R 31 108
TRIAMTERENE-HCTZ 75 75 31 61
MIRTAZAPINE 74 74 33 21
RANITIDINE HCL 74 65 33 22
CARBIDOPA-LEVODOPA 73 73 35 32
FLUTICASONE PROPIONATE 69 67 36 65
GLIPIZIDE 67 66 37 45
DIOVAN 66 60 38 67
PROAIR HFA 66 58 38 120
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 56 40 122
CARVEDILOL 64 64 41 31
QUETIAPINE FUMARATE 60 60 42 28
PRAVASTATIN SODIUM 59 59 43 79
DOXAZOSIN MESYLATE 58 58 44 83
CLOPIDOGREL 55 55 45 50
TRAZODONE HCL 54 42 46 14
LANTUS 54 54 46 27
IBUPROFEN 52 44 48 145
BISOPROLOL-HYDROCHLOROTHIAZIDE 52 46 48 145
OXYCODONE HCL 51 36 S2 50 24
AMITRIPTYLINE HCL 51 47 R 50 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.